Latest Enterprise Agreements News

Praemium’s total Funds Under Administration surged 21% to $77.9 billion in FY26, driven by strong platform net inflows and robust growth in non-custodial portfolio administration.

AdNeo Limited achieved a record positive operating cash flow of $451k in Q4 FY26 and secured significant customer contracts, setting the stage for disciplined growth in FY27.

Aspermont Limited now expects sustainable operating cashflow positivity in the second half of FY27, delayed from Q3 FY26 due to extended sales cycles on key enterprise contracts.

Aspermont Limited reported a 15% revenue increase in Q2 FY26, driven by a surge in non-subscriptions revenue and steady subscriptions. The company is progressing its AI-enabled data platform build, funded internally, with cash flow positivity expected soon.

Singular Health has received a US$500,000 payment from Provider Network Solutions following the deployment of an additional 500 3DICOM MD® licenses, marking progress in commercial adoption and cost-saving benefits within a major US healthcare network.

AdNeo Limited has locked in a five-year contract worth approximately $246,400 to deliver and host a custom-branded learning platform for Amplitude Energy, reinforcing its foothold in Australia's energy sector.

xReality Group Limited has reported a robust half-year performance with revenue climbing 41% to $10.4 million, driven by rapid expansion of its Operator XR platform. EBITDA surged 190%, underscoring the company’s successful pivot to software-led immersive training solutions.

Asset Vision has reported a robust 38% increase in annual recurring revenue to $5.2 million in the first half of FY26, underpinned by new council contracts and AI-driven platform upgrades. The company’s positive cash EBITDA and strategic focus on scalable growth signal strong momentum in the critical infrastructure SaaS market.

Woolworths Group posted a modest 1.7% revenue increase to $69.1 billion for the 52 weeks ending June 2025, while earnings before interest and tax (EBIT) fell 12.6%, weighed down by challenges in its Australian Food and BIG W segments.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Data # 3 Limited has delivered a robust FY25 performance with revenues rising 5.8% to $863 million and net profit up 11.3%, supported by strong growth across its core business segments and a 10.2% dividend increase.

Lindsay Australia reported a 5.6% revenue increase in FY25, driven by strategic acquisitions and growth in transport and rural sectors, even as margins tightened amid competitive pressures and higher costs.